GSK shares surge as the drugmaker raises its 2031 sales target to over £40bn, boosts dividends, and announces a £2bn share buyback plan.
European shares were flat in early trade on Wednesday, as gains led by healthcare stocks following drugmaker Novo Nordisk’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback